<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04194437</url>
  </required_header>
  <id_info>
    <org_study_id>OCS-LVR-092019</org_study_id>
    <nct_id>NCT04194437</nct_id>
  </id_info>
  <brief_title>OCS Liver DCD Trial</brief_title>
  <official_title>Prospective Trial to Evaluate the Effectiveness of The Portable Organ Care System (OCS) Liver for Preserving, Optimizing and Assessing Currently Seldom Utilized DCD Donor Livers for Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TransMedics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TransMedics</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate the safety and effectiveness of the OCS Liver System to preserve, optimize the
      condition, and assess levers from DCD donors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate the safety and effectiveness of the OCS™ Liver to preserve, optimize the
      condition and assess livers from DCD donors that currently are seldom used for liver
      transplants due to limitations of cold static storage with extended warm ischemic time and
      older donors.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">June 30, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2026</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Liver graft survival through 6 months post-transplant</measure>
    <time_frame>6 months</time_frame>
    <description>Evaluation of graft survival as defined per UNOS data collection criteria for graft status after liver transplantation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of donor liver utilization after OCS liver perfusion</measure>
    <time_frame>OCS liver perfusion, on average about 6 hours</time_frame>
    <description>The number of eligible donor livers that were instrumented and perfused on OCS liver system and successfully transplanted, divided by the number of eligible donor livers that were instrumented and perfused on OCS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of ischemic biliary cholangiopathy at 6 months post-transplant</measure>
    <time_frame>6 months</time_frame>
    <description>Evaluation of ischemic biliary complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Early Allograft Dysfunction (EAD) or primary non-function</measure>
    <time_frame>7 days</time_frame>
    <description>Evaluation of EAD via AST, Bilirubin and INR</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Patient and graft survival</measure>
    <time_frame>Day 30</time_frame>
    <description>Survival as determined by follow-up visit/call with patient or health care provider.</description>
  </other_outcome>
  <other_outcome>
    <measure>Patient and graft survival</measure>
    <time_frame>6 months</time_frame>
    <description>Survival as determined by follow-up visit/call with patient or health care provider.</description>
  </other_outcome>
  <other_outcome>
    <measure>Patient and graft survival</measure>
    <time_frame>12 months</time_frame>
    <description>Survival as determined by follow-up visit/call with patient or health care provider.</description>
  </other_outcome>
  <other_outcome>
    <measure>Patient and graft survival</measure>
    <time_frame>24 months</time_frame>
    <description>Survival as determined by follow-up visit/call with patient or health care provider.</description>
  </other_outcome>
  <other_outcome>
    <measure>Patient and graft survival</measure>
    <time_frame>36 months</time_frame>
    <description>Survival as determined by follow-up visit/call with patient or health care provider.</description>
  </other_outcome>
  <other_outcome>
    <measure>Patient and graft survival</measure>
    <time_frame>48 months</time_frame>
    <description>Survival as determined by follow-up visit/call with patient or health care provider.</description>
  </other_outcome>
  <other_outcome>
    <measure>Patient and graft survival</measure>
    <time_frame>60 months</time_frame>
    <description>Survival as determined by follow-up visit/call with patient or health care provider.</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Liver Transplant</condition>
  <arm_group>
    <arm_group_label>OCS Preserved Livers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This is a single-arm trial of OCS preserved livers used for transplantation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OCS Liver System</intervention_name>
    <description>The OCS Liver System will be used to preserve, optimize and assess livers from DCD donors.</description>
    <arm_group_label>OCS Preserved Livers</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Registered primary liver transplant candidate

          -  Age ≥ 18 years

          -  Obtained informed consent

        Exclusion Criteria:

          -  Acute, fulminant liver failure

          -  Prior solid organ or bone marrow transplant

          -  Ventilator dependent on day of transplant/donor organ offer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Scripps</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Meyer</last_name>
      <phone>858-554-4340</phone>
      <email>meyer.michelle@scrippshealth.org</email>
    </contact>
    <investigator>
      <last_name>Christopher L Marsh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Marc Melcher, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tampa General</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Amy Lu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kerry Crisalli</last_name>
      <phone>617-643-4087</phone>
      <email>kcrisalli@mgh.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>James Markmann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Crombez</last_name>
      <phone>313-916-4596</phone>
      <email>ccrombe1@hfhs.org</email>
    </contact>
    <contact_backup>
      <last_name>Iman Francis</last_name>
      <email>lfranci1@hfhs.org</email>
    </contact_backup>
    <investigator>
      <last_name>Marwan Abouljoud, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Montefiore</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Juan Rocca, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Brandy Haydel</last_name>
      <phone>212-241-0255</phone>
      <email>brandy.haydel@mountsinai.org</email>
    </contact>
    <investigator>
      <last_name>Sander Florman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carolinas Medical Center</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>David Levi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio State University Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zachary Polcyn</last_name>
      <phone>614-366-9277</phone>
      <email>Zachary.Polcyn@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Sylvester Black, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwest</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Emily Carlson</last_name>
      <phone>214-648-7609</phone>
      <email>emily.carlson@utsouthwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Malcolm MacConmara, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Houston Methodist</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Isioma Agboli, MD</last_name>
      <phone>281-414-9916</phone>
      <email>iagboli@houstonmethodist.org</email>
    </contact>
    <investigator>
      <last_name>Ashish Saharia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78249</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jillian Woodworth</last_name>
      <phone>210-567-9229</phone>
      <email>woodworthj@uthscsa.edu</email>
    </contact>
    <investigator>
      <last_name>Tarunjeet S Klair, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Chandra Bhati, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>December 9, 2019</study_first_submitted>
  <study_first_submitted_qc>December 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 11, 2019</study_first_posted>
  <last_update_submitted>June 4, 2020</last_update_submitted>
  <last_update_submitted_qc>June 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

